Baxter International Inc.

Market cap: $20,333,410,577

Exchange: NYS

Sector: Health Technology

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Key Statistics

Company Name

Baxter International Inc.

Average Volume (10 days)

3,172,665

Average Volume (30 days)

3,249,649

Moving Average (50 days)

$42.22

Moving Average (200 days)

$38.01

Ex-Divided Date

Feb 29, 2024

Dividend Yield

0.0287

P/E Ratio

7.6557

Market Cap

20,333,410,577

Shares Outstanding

507,827,437

52-Week High Split Adjust Only

49.12

52-Week Low Split Adjust Only

30.55

Employee Count

32,403

Beta

0

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

1.1474

Price Changes

Past 5 days

-0.05%

Past 30 days

-0.04%

Past 3 months

0.01%

Past 6 months

0.28%

Past year

-0.04%

Past 2 years

-0.45%

Past 5 years

-0.45%

Max % Change

1.16%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Baxter International Inc.BAX3.494.8923.43.493.74
Peer AvgN/A5.4813.9921.95.485.83
Thermo Fisher Scientific Inc.TMO5.145.2621.15.145.50
Stryker Corp.SYK6.547.1227.86.547.27
Medtronic PlcMDT6.113.3622.36.116.67
Boston Scientific Corp.BSX5.973.8526.95.976.67
Becton, Dickinson And Co.BDX3.732.8318.83.734.47
Cardinal Health, Inc.CAH0.109.099.40.100.12
Halozyme Therapeutics Inc.HALO17.8087.2330.017.8018.13
ICU Medical, Inc.ICUI3.502.9030.03.503.16
Owens & Minor, Inc.OMI0.394.2711.30.390.49